Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joseph Martel
Observed names:
Martel, Joseph,
Martel,Joseph
Institution:
Martel
Observed institutions:
Martel,
Tauber Eye Center
ORCID:
0000-0001-8888-9286
Observed ORCID:
0000-0001-8888-9286
OpenAlex ID:
A5024161557
NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction
2022
·
Joseph Tauber
, Gregg J. Berdy
, et al.
·
Ophthalmology
·
110
Recombinant human nerve growth factor (cenegermin) for moderate-to-severe dry eye: phase II, randomized, vehicle-controlled, dose-ranging trial
2024
·
David Wirta
, William Lipsky
, et al.
·
BMC Ophthalmology
·
17
PDF
Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study
2022
·
Lee Shettle
, Eugene McLaurin
, et al.
·
Clinical ophthalmology
·
16
PDF
Reply
2017
·
Rishi P. Singh
, Robert Lehmann
, et al.
·
Ophthalmology
·
1
Show more works
View as search
Works count:
11
Citation count:
144
H-index:
3
I10-index:
3
Year
Topic
Type
